Navigation Links
Mangrove Partners Agrees to Support Amended Transaction Between Nabi Biopharmaceuticals and Biota Holdings
Date:9/19/2012

NEW YORK, Sept. 19, 2012 /PRNewswire/ -- The Mangrove Partners Fund, L.P. ("Mangrove Partners"), one of the largest stockholders of Nabi Biopharmaceuticals (NasdaqGS: NABI), announced today that it is pleased that Nabi Biopharmaceuticals has responded to the concerns of its stockholders by amending the terms of the Transaction between Nabi Biopharmaceuticals and Biota Holdings. The amended Transaction now returns greater cash to Nabi stockholders and provides increased certainty through the use of a collar mechanism to protect against drops in the price of Biota shares.  Mangrove believes that the total expected value of the revised transaction is approximately $1.99 per share, which is comprised of $1.04 per share in cash(1) and the equivalent value of $0.95 per share based on Biota stock price(2). We believe that this potentially represents a 17% premium(3) to the terms of the original Transaction using Biota's stock price as of the close on September 18, 2012, a 9% premium(4) to the discounted value under a formal Delaware liquidation, and a 7% premium(5) to the undiscounted value under a formal Delaware liquidation. The average of the foregoing premiums is 11%.  Mangrove Partners believes that these changes adequately address its concerns with the Transaction and has therefore agreed to (i) terminate its solicitation opposing the Transaction, (ii) unequivocally support the amended Transaction on its current economic terms and (iii) vote in favor of all of the Transaction Proposals at the upcoming Special Meeting, which will be adjourned or postponed to a new date that Nabi will announce in the coming days.

Nathaniel August, founder and portfolio manager of Mangrove Partners, states, "We commend the executive and management teams at Nabi Biopharmaceuticals and Biota Holdings for amending the proposed Transaction on terms more favorable to Nabi stockholders. We believe the amended tra
'/>"/>

SOURCE Mangrove Partners Fund, L.P.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
2. Bluechiip Signs Strategic Partnership with Gentris Corporation
3. UBM Announces Partnership Agreement With Trade Organisation - SIPPO
4. Antares Vision and Xyntek Inc. Announce Strategic Partnership for E-pedigree and Serialization Turn-Key Solution Delivery
5. Thomson Reuters Partners with CHDI Foundation to Develop Systems Biology Tools for Huntingtons Disease
6. Patient Advocate Foundation and Jazz Pharmaceuticals Announce Partnership for Narcolepsy CareLine
7. The PROOF Centre of Excellence Partners with OriGene Technologies on Heart & Kidney Transplant Biomarker Program
8. NineSigma Partners with Scientists Without Borders to Find New Sustainable Packaging for Micronutrient Powders that Combat Malnutrition
9. HemoShear Partners with Expression Analysis (EA) to Develop a Human Drug-Induced Vascular Response Database
10. Elsevier and The Geological Society of London Take Home the 2012 Getenergy Award for Education / Industry Partnership
11. Clean Energy Alliance and the Manufacturing Extension Partnership Announce New Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... CO (PRWEB) August 27, 2014 Flagship ... analysis services to the pharmaceutical and medical device ... expansion. The fast growing company has consolidated its ... Aurora and Boulder to Westminster, CO, just north of ... Histology Lab, 7575 W. 103rd Ave., Suite 100, Westminster, ...
(Date:8/27/2014)... , Aug. 27, 2014 Tris Pharma, ... delivery technologies, today announced that it has been selected ... & Industry Association,s 2014 Awards for Excellence ... by an independent panel of judges from SCORE (Counselors ... Award winners will be honored at a gala event ...
(Date:8/27/2014)... 2014 According to the 2013 Raw ... the look and feel of markets for raw materials ... ingredients will push for more branded, science-backed products.” , ... strong market growth in the last decade as consumers ... and cosmetics to fit a more ‘wellness’ lifestyle approach. ...
(Date:8/26/2014)... Scientists have developed what they believe is the ... made in sheets only three atoms thick. , ... two of these single-layer semiconductor materials can be ... a heterojunction. This result could be the basis ... diodes, or LEDs, and solar technologies. , "Heterojunctions ...
Breaking Biology Technology:Flagship Biosciences Announces Relocation and Expansion 2Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2
... SUNNYVALE, Calif., Nov. 13 Voler,( http://www.volersystems.com ) ... design capabilities beyond prototypes and custom test,systems to ... human use.,"Voler continues to invest in upgrades to ... our multidisciplinary team," stated Walt Maclay,president of Voler. ...
... Future Healthcare and Education, OLDSMAR, Fla., Nov. ... largest and most established private,cord blood banks and ... agreement as an exclusive retailer with Upromise(R) the,largest ... Since,2004, Cryo-Cell has been the only cord blood ...
... Requires Only Weekly Dosing, SAN DIEGO, Nov. ... trial data demonstrating that ARX201, the company,s,long-acting human ... Serono, normalized insulin-like growth factor I (IGF-I) levels,while ... adults,with Growth Hormone deficiency. The results of this ...
Cached Biology Technology:Voler Expands Medical Device Design Capabilities 2Voler Expands Medical Device Design Capabilities 3Cryo-Cell Renews Upromise Industry-Exclusive Agreement 2Cryo-Cell Renews Upromise Industry-Exclusive Agreement 3Cryo-Cell Renews Upromise Industry-Exclusive Agreement 4Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated 2Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated 3
(Date:8/27/2014)... Gamblers are greedy bird-brains, University of Warwick research finds ... when they make risky decisions, new research has shown. ... University of Warwick,s Department of Psychology, conducted tests that ... more likely to gamble for high-value than low-value rewards. ... argue that the test results show the important role ...
(Date:8/26/2014)... have developed algorithms to identify weak spots in tendons, ... technology, which needs to be refined before it is ... strains and tiny injuries in the body,s tissues long ... online Aug. 27 in the Journal of the ... nexus of the physical and life sciences. , "Tendons ...
(Date:8/26/2014)... the University of Warwick have provided the first ... protein is linked to early signs of dementia. ... research found that the absence of the protein ... in the nervous system. These changes were shown ... of dementia, including restricted learning and memory formation ...
Breaking Biology News(10 mins):Gamblers are greedy bird-brains, University of Warwick research finds 2New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3Lack of naturally occuring protein linked to dementia 2
... FRANCISCOSatellite observations have revealed the first direct evidence of ... sheet, tarnishing the ice with soot and making it ... the American Geophysical Union meeting this week, an Ohio ... and Infrared Pathfinder Satellite Observation (CALIPSO) satellite, which captured ...
... most powerful X-ray laser, has revealed the three dimensional structure ... causes African trypanosomiasis (or sleeping sickness) in humans. ... cathepsin B enzyme, it will be possible to design new ... causes sleeping sickness, leaving the infected human unharmed. The ...
... recent University of Colorado Cancer Center review in the journal ... promising cancer prevention properties. Meanwhile, an ongoing clinical trial is ... of colon cancer. "While I have been trained ... to deliver bioactive, cancer fighting compounds with food, and this ...
Cached Biology News:Fire and ice: Wildfires darkening Greenland snowpack, increasing melting 2X-ray laser helps slay parasite that causes sleeping sickness 2Clinical trial tests rice bran to prevent cancer 2
... This goat anti-rabbit IgG FITC ... antibody' for immunofluorescent staining on tissues ... antibody is generated in rabbits. It ... controls, such as omitting the primary ...
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Request Info...
HAS1 (C-14)...
Biology Products: